Bioavailability of Apixaban Crushed Tablet
NCT02101112 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 69
Last updated 2016-03-03
Summary
The purpose of this study is to determine whether the bioavailability of apixaban crushed tablets suspended in water or mixed with applesauce is similar to the bioavailability of apixaban whole tablets administered orally.
Conditions
Interventions
- DRUG
-
Apixaban
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
More Related Trials
-
A Study of Apalutamide Administered Orally as Whole Tablets and as a Mixture in Applesauce in Healthy Participants
NCT03802682 ·Status: COMPLETED ·Phase: PHASE1
-
Pivotal BE Study of TAH3311 ODF vs ELIQUIS® Tablet Under Fasted Condition in Healthy Volunteers
NCT06689436 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Celecoxib Bioavailability in Healthy Subjects
NCT00296127 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy Volunteers
NCT05995119 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants
NCT01464450 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Bioavailability of Apremilast Oral Suspension Relative to Tablet and to Assess Effect of Food on the Pharmacokinetics (PK) of the Oral Suspension
NCT02641353 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers Including the Influence of Food on the Bioavailability of 10 mg BI 1356 BS
NCT02180503 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of Different Applications of Dabigatran in Healthy Volunteers
NCT02171611 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Relative Bioavailability of Branebrutinib, From a Tablet Formulation to the Capsule Formulation, the Effect of Food on the Bioavailability of Branebrutinib From a Tablet Formulation, and the Safety and Drug Levels of Branebrutinib From a Tablet Formulation in Healthy Participants
NCT05303220 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers
NCT02044367 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of Three Immediate-Release Tablet Formulations of ABBV-903 in Healthy Adult Volunteers
NCT06078202 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety, Pharmacodynamics, and Pharmacokinetics of BIBT 1011 BS in Healthy Subjects
NCT02182037 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Bioavailability of BMS-986205
NCT03374228 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of Dabigatran and Amiodarone After Multiple Oral Administrations of Dabigatran Etexilate With or Without Amiodarone as Single Dose in Healthy Male and Female Volunteers
NCT02171026 ·Status: COMPLETED ·Phase: PHASE1
-
A Relative Bioavailability Study of Revatio for the Crushed Tablets, Extemporaneously Prepared Formulation, and the Intact Tablets at 20 mg Dose in Healthy Volunteers
NCT01027117 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of Single Doses of Dabigatran Etexilate in Healthy Volunteers
NCT02173717 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.
NCT01887626 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male Subjects
NCT02710630 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of K0706 in Healthy Subjects
NCT03316820 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male Subjects
NCT02182388 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Learn How Much Rivaroxaban Gets Into the Blood When Taken in Different Forms and How Safe They Are in Healthy Men
NCT04727021 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy Volunteers
NCT02182414 ·Status: COMPLETED ·Phase: PHASE1
-
Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis
NCT04874428 ·Status: RECRUITING ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food
NCT01286571 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of 3 Different Formulations of BI 207127 in Healthy Male Volunteers
NCT01535638 ·Status: COMPLETED ·Phase: PHASE1